← Eichor
Study identifier: NCT06105749 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Biennial CEM in Women With a Personal History of Breast Cancer

Condition: Breast Cancer · Breast Neoplasms · Breast Cancer Female  ·  Sponsor: Wendie Berg

PhaseNA
Planned participants1500
Who can joinFemale, 30 Years to 79 Years
Healthy volunteersYes

About this study

This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Wendie Berg, MD, PhD  ·  412-641-8278  ·  bergwa@upmc.edu

McKenna Rigling, MS  ·  412-641-8278  ·  riglingmm@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (6)

UPMC Magee-Womens Imaging - Bethel ParkBethel Park, Pennsylvania, United StatesRecruiting
UPMC Magee at the Lemieux Sports ComplexCranberry Township, Pennsylvania, United StatesRecruiting
Magee Womancare MonroevilleMonroeville, Pennsylvania, United StatesRecruiting
Magee-Womens HospitalPittsburgh, Pennsylvania, United StatesRecruiting
Hillman Cancer Center at ShadysidePittsburgh, Pennsylvania, United StatesRecruiting
UPMC West Mifflin Outpatient CenterWest Mifflin, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06105749